Supported by george james ltd, specialists in Recruitment, Training and Corporate Development in the Life Science industry, www.georgejamesltd.co.uk

February 2017
Latest News in Personalized and Precision Medicine

Roche introduces the Access Accelerated initiative to tackle the challenge of non-communicable diseases read on...
2017 could be the breakout year for these 5 biotechs read on...
FDA further explains delay on LDT guidance read on...
Bristol-Myers Squibb and GeneCentric Diagnostics partner in new research collaboration read on...
Epic Sciences AR-V7 Study raises questions for upcoming head-to-head assay comparison read on...
Senate approves first step to repealing Obamacare read on...
Biodesix and Bioyong announce agreement for joint development and commercialization of VeriStrat test in greater China read on...
Biocept lands Blue Cross Blue Shield Texas in-network provider agreement read on...
MRD eradication with alemtuzumab consolidation improves OS, PFS in CLL read on...
Japan's Takeda to buy US cancer drug maker Ariad in $5.2bn deal read on...
FDA grants Genentech's cancer immunotherapy TECENTRIQ (Atezolizumab) priority review in additional type of advanced bladder cancer read on...
Counsyl lays off oncology sales team read on...
Effects on laboratories - changes in healthcare spending during the Obama administration read on...
Medivo announces the launch of Prognos read on...
Pancreatic cancer study finds NGS-based liquid, tissue biopsies provide discordant results read on...
Hologic HIV-1 Quant test wins FDA clearance read on...
VolitionRx gets CE mark for colorectal cancer screening test read on...
Younger, older prostate cancer cases marked by distinct expression patterns read on...
Myriad disputes research, reasoning underpinning Medicare proposal to end Vectra DA coverage read on...
SMN1 mutation - SMA first drug approved read on...
IDH2 may become more important in AML therapy read on...
Helomics completes restructuring to clinical CRO read on...
Roche will focus on Genia's Nanopore technology for Dx market after ending deal with PacBio read on...
Foundation BRCA CDx is first NGS companion test to get FDA nod read on...
This month in Diaceutics news

[Media Mention] In 2016, personalized medicine saw more CDx deals, flexible FDA, no LDT guidance read on...
[Media Mention] Annual Diaceutics report illuminates state of diagnostic ecosystem in the pharmaceutical industry read on...
[Expert Insight] Pharma Finance and the Trump Effect read on...
[Webinar] Which Pharma Companies Are Ready For Precision Medicine in 2017? Benchmarking, Financial Risks and Predictions read on...


     

© 2016 Diaceutics Group. All rights reserved.